Skip to content
Recall Observatory FDA recall evidence

Drug product

Glenmark Ranitidine Tablets USP 300 mg Rx Only 30 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-249-30

D-0641-2020

December 17, 2019

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 84516
Status
Ongoing
Classification
Class II
Quantity
98,988 bottles
Official record key
drug-enforcement:D-0641-2020

Official wording

Reason: CGMP Deviations: Presence of NDMA impurity detected in product.

Code information: 7701429A 7701522A 7702255A 7704745A 19190456 19190472 19190490

Distribution pattern: Natiowide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    NDMA impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations